Conceptual and endpoint models
Conceptual models increasingly underlie much PRO research. They are used to represent the relationship between disease symptoms, treatment and the experiences of a patient. Within PRO research, conceptual models provide a credible basis for developing new PRO measures and for developing endpoint models. They also provide a sound scientific foundation for economic modeling and more broadly for healthcare decision-making.
Endpoint models are an essential component of every FDA labeling claim and PRO evidence dossier. Both endpoint models and conceptual models are developed from literature review, interviews with patients and specialists, and input from clinical teams.
Oxford Outcomes is a well-established market leader in the development of conceptual and endpoint models, having developed disease-specific, symptom-specific and treatment-specific models. Our team brings together opinion-leading scientific expertise, knowledge of marketplace and regulatory landscapes, together with consultancy and communication skills. This team is an active contributor to the scientific advancement of conceptual and end point modeling. For more about the team and their recent publications click here.
Our modeling methods draw together the benefits of our consultancy expertise, a well-founded scientific approach, along with focused project management. Our team seeks practical and effective solutions wherever possible, but will innovate to produce optimal methods and results. These methods rely on our team always being at the leading edge of service development.